Abstract
TCF-4 is the main effector of the Wnt/Wingless signalling pathway. As with other TCF/LEF factors, numerous alternative splicings at its 3′ end affect its expression. Such a mechanism leads to the synthesis of numerous TCF-4 isoforms among which some contain binding domains for CtBP, an ubiquitous transcriptional corepressor. Of interest, we described a frequent TCF-4 frameshift mutation in mismatch-repair deficient colorectal cancers (MSI-H cancers) that leads to the selective loss of TCF-4 isoforms with CtBP binding abilities. We provide here data that argue for a partial colocalization of CtBP with TCF-4 isoforms containing CtBP binding domains in cellulo, and for a functional role of CtBP in repressing TCF-4 mediated transcription. We also demonstrate that such a colocalization is not observed in MSI-H colorectal cancer cells that harbour the TCF-4 frameshift mutation, and that CtBP is not able to repress TCF-4-mediated transcription in this context. Taken together, our results strongly suggest that CtBP would play a role in regulating TCF-4 mediated transcription upon its binding with some TCF-4 isoforms encoded by alternatively spliced mRNA. They also suggest a role for TCF-4 frameshift mutation during MSI-H colorectal tumour progression, by regulating the relative proportion of the different TCF-4 isoforms.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin JP et al. (1993). Science 260: 812–816.
Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R et al. (1996). Nature 382: 638–642.
Brannon M, Brown JD, Bates R, Kimelman D, Moon RT . (1999). Development 126: 3159–3170.
Brantjes H, Roose J, van de Wetering M, Clevers H . (2001). Nucleic Acids Res 29: 1410–1419.
Clevers H, van de Wetering M . (1997). Trends Genet 13: 485–489.
Duval A, Gayet J, Zhou XP, Iacopetta B, Thomas G, Hamelin R . (1999). Cancer Res 59: 4213–4215.
Duval A, Hamelin R . (2002). Cancer Res 62: 2447–2454.
Duval A, Rolland S, Tubacher E, Bui H, Thomas G, Hamelin R . (2000). Cancer Res 60: 3872–3879.
El Bchiri J, Buhard O, Penard-Lacronique V, Thomas G, Hamelin R, Duval A . (2005). Hum Mol Genet 14: 2435–2442.
Gayet J, Zhou XP, Duval A, Rolland S, Hoang JM, Cottu P et al. (2001). Oncogene 20: 525–532.
Hamada F, Bienz M . (2004). Dev Cell 7: 677–685.
Holbrook JA, Neu-Hilik G, Hentze MW, Kulozik AE . (2004). Nat Genet 36: 801–808.
Ionov Y, Peinado M, Malkhosyan S, Shibata D, Perucho M . (1993). Nature 363: 558–561.
Jourdan F, Sebbagh N, Comperat E, Mourra N, Flahault A, Olschwang S et al. (2003). Virchows Arch 443: 115–121.
Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW et al. (1997). Science 275: 1784–1787.
Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ et al. (1998). Nat Genet 19: 379–383.
Ruckert S, Hiendlmeyer E, Brueckl WM, Oswals U, Beyser K, Dietmaier W et al. (2002). Cancer Res 62: 3009–3013.
Thibodeau SN, Bren G, Schaid D . (1993). Science 260: 816–819.
Valenta T, Lukas J, Korinek V . (2003). Nucleic Acids Res 31: 2369–2380.
Acknowledgements
We thank Andreas Jung, Bert Vogelstein and Bohdan Wasylyk for the generous gift of expression vectors pΔ45βcatenin, pTCF-4(A)9, pTCF-4(A)8 and pCtBP. We also thank Barry Iacopetta for critical reading of the manuscript. This work was partly supported by grants from the Association Nationale de Recherche sur le SIDA (credit number 03/162) and from the Association pour la Recherche contre le Cancer (credit number 3301). JEB was recipient of a fellowship from the Ministère Français de la Recherche (MRT). PCD was recipient of a fellowship from the Association pour la Recherche contre le Cancer.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cuilliere-Dartigues, P., El-Bchiri, J., Krimi, A. et al. TCF-4 isoforms absent in TCF-4 mutated MSI-H colorectal cancer cells colocalize with nuclear CtBP and repress TCF-4-mediated transcription. Oncogene 25, 4441–4448 (2006). https://doi.org/10.1038/sj.onc.1209471
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209471
Keywords
This article is cited by
-
TCF 4 tumor suppressor: a molecular target in the prognosis of sporadic colorectal cancer in humans
Cellular & Molecular Biology Letters (2020)
-
C-terminal of E1A binding protein 2 promotes the malignancy of osteosarcoma cells via JAK1/Stat3 signaling
Journal of Cell Communication and Signaling (2020)
-
C-terminal binding protein-2 regulates response of epithelial ovarian cancer cells to histone deacetylase inhibitors
Oncogene (2013)
-
Cell type-specific binding patterns reveal that TCF7L2 can be tethered to the genome by association with GATA3
Genome Biology (2012)
-
Molecular Function of TCF7L2: Consequences of TCF7L2 Splicing for Molecular Function and Risk for Type 2 Diabetes
Current Diabetes Reports (2010)